Phase-2 Investment Plan – IP investment an investment grade private deal
OM Sciences plans to launch a second round of funding to accelerate research, secure additional intellectual property, and introduce 8 essential health sensors and 2 security check point sensors. By selling 20% of OM shares, OM aims to raise HKD XX million within 12 months. The newly developed devices will be marketed through Kickstarter and Indiegogo, followed by listings on Amazon and Alibaba. Partnerships with global exporters and participation in the Hong Kong Electronics Fair will support worldwide promotion. The second-year export target is USD 3.0 million, with an expected 20% net profit margin.
Expansion Goals and Telemedicine Potential
If OM successfully achieves its first-year targets, the second round of fundraising will target HKD XX million to commercialize medical-grade conjugated organic polymer sensors for home health monitoring. The growing demand for Telemedicine, driven by the global shortage of healthcare professionals, presents a significant opportunity. Companies like Tempus have demonstrated the tremendous market need for innovative health-monitoring solutions. And this approach has been a certified solution for managing early-release COVID-19 cases.
OM’s conjugated organic polymer sensors offer unparalleled benefits for Telemedicine, including continuous, real-time, wireless or wired data monitoring continuously without recalibration. These features are critical for remote healthcare applications and surpass the capabilities of conventional sensors. Many organic semiconductors are biocompatible, making them ideal for health monitoring applications.
For a deeper dive into the role of sensors in medical diagnostics and monitoring, watch this 58-minute YouTube video on Ele-medicine’s evolution and the regulatory challenges being overcome due to global demand.
Phase-2 Product Launch Plan
In the second 12 months, OM will launch the following 8 essential health sensors targeting medical-grade quality for home health monitoring, with the potential to obtain full medical-grade certification in the future:
1. Heart Rate Sensor: Monitors pulse for cardiovascular health.
2. Blood Pressure Sensor: Assists in hypertension and hypotension management.
3. SpO₂ Sensor: Measures blood oxygen levels for respiratory health monitoring.
4. Temperature Sensor: Detects fever or infection indicators.
5. Hydration Sensor: Evaluates skin hydration for health insights.
6. Stress Sensor: Tracks cortisol levels via sweat for stress management.
7. pH Sensor: Analyzes skin or fluid pH for chronic disease management.
8. ECG Sensor: Records heart activity to detect arrhythmias.
OM will also develop 2 additional security check point sensors for crowdfunding and online sales, targeting checkpoint applications:
9. Explosive Sensor: Detects explosives for enhanced security.
10. Drug Sensor: Identifies illicit substances for checkpoint screening.
OM’s Unique Value Proposition
OM’s organic conjugated polymer sensors enable continuous, gap-free health monitoring with no recalibration required, offering a critical advantage for Telemedicine. These sensors address the growing need for remote patient monitoring, providing biocompatible, cost-effective, and reliable solutions for both health and security sectors. By combining innovation, scalability, and medical-grade quality, OM is positioned to lead the next wave of sensor technology in Telemedicine and beyond. With all the mentioned advantages, which enabled OM Security Checkpoint Detectors to smell what we can’t smell (drug and explosives), by building a sensor grid to have a no blind sport sensing.
Application of HK government funds HKD 5.0M
a. Partnership Research Programme (PRP)
https://www.itf.gov.hk/en/funding-programmes/supporting-research/prp/index.html
Key Features
• Provide matching funding support for Collaborative R&D projects.
• Maximum Project Duration: 36 months.
• Industry Sponsorship: at least 50% of the total project cost.
Intellectual Property (IP) Rights Ownership: industry co-applicant if it contributes at least 50% of the total project cost.
b. Enterprise Support Scheme (ESS)
https://www.itf.gov.hk/en/funding-programmes/supporting-research/ess/index.html
Key Features
• Provides on a dollar-for-dollar matching basis.
• Maximum Funding Support: $10 million per approved project.
• Maximum Project Duration: 24 months in general.
• Intellectual Property Rights Ownership: recipient company.
• Recoupment of Government’s Contribution: NOT required.
• Benefit Sharing of Commercialised R&D Results: NOT mandatory.